BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26782462)

  • 1. Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
    Ma YB; Li GX; Hu JX; Liu X; Shi BM
    Genet Mol Res; 2015 Dec; 14(4):18153-9. PubMed ID: 26782462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.
    Li BS; Liu H; Yang WL
    Genet Mol Res; 2015 Dec; 14(4):16372-8. PubMed ID: 26662432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
    Zhu Z; Xu Y; Du J; Tan J; Jiao H
    J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
    Yang Y; Song KL; Chang H; Chen L
    Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
    Liu K; Li G; Fan C; Diao Y; Wu B; Li J
    J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.
    Kanno S; Nosho K; Ishigami K; Yamamoto I; Koide H; Kurihara H; Mitsuhashi K; Shitani M; Motoya M; Sasaki S; Tanuma T; Maguchi H; Hasegawa T; Kimura Y; Takemasa I; Shinomura Y; Nakase H
    Carcinogenesis; 2017 Apr; 38(4):425-431. PubMed ID: 28186267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
    Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.
    Sun P; Sun D; Wang X; Liu T; Ma Z; Duan L
    Cancer Biomark; 2015; 15(4):391-6. PubMed ID: 26406866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.
    Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F
    Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
    Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
    Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
    Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-335 represents an independent prognostic marker in cervical cancer.
    Wang C; Jiang T
    Tumour Biol; 2015 Aug; 36(8):5825-30. PubMed ID: 25712373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.